Clinical Neuroscience Grand Rounds

Nicholas Boulis, MD, PhD, is a professor in the Department of Neurosurgery and serves as director of the Gene and Cell Therapy for Neurorestoration Laboratory at Emory University School of Medicine. He is also on faculty at Georgia Tech’s Parker H. Petit Institute for Bioengineering and Bioscience Center for Regenerative Engineering and Medicine. Boulis graduated from Yale College and received his MD from Harvard Medical School in Boston, Massachusetts. He completed his postdoctoral fellowship and his residency in neurological surgery at University of Michigan Medical Center in Ann Arbor, Michigan. He has extensive expertise in the field of gene transfer to the nervous system. His lab pursues novel and advanced treatments for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, as well as Parkinson’s disease, spinal muscular atrophy, and refractory pain conditions. His lab has developed a variety of gene therapy vectors and has focused on the development of techniques for safe and accurate injection of therapeutics into the brain and spinal cord.

Yale Zoom

You are invited to a scheduled Zoom meeting. Zoom is Yale’s audio and visual conferencing platform.

Topic: Clinical Neuroscience Grand Rounds, Department of Neurosurgery

Join from PC, Mac, Linux, iOS or Android: https://yale.zoom.us/j/91697072585?pwd=sq4tdJkfk7k678hM0oTD5MD2GHkSTm.1

Password: 655399

Or Telephone：203-432-9666 (2-ZOOM if on-campus) or 646 568 7788

One Tap Mobile: +12034329666,, 91697072585# US (Bridgeport)

Meeting ID: 916 9707 2585

International numbers available: https://yale.zoom.us/u/aczoNdpjUv

Program Objective(s):

1. Describe methods of cell transplantation for the spinal cord.

2. Describe methods of gene delivery to the spinal cord.

3. Define chemogenetics, and its application to pain and spasticity.

CME accreditation and disclosure statements:

Accreditation Statement: Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement: Yale School of Medicine designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy: It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs. All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients) that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Mitigation of Financial Relationships Statement: Yale CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible companies. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.